The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-23
DOI
10.3389/fnins.2019.00015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
- (2018) Caroline Moreau et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibition of protein misfolding and aggregation by natural phenolic compounds
- (2018) Zohra Dhouafli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prion protein modulates iron transport in the anterior segment: Implications for ocular iron homeostasis and prion transmission
- (2018) Ajay Ashok et al. EXPERIMENTAL EYE RESEARCH
- Metal Ion Effects on Aβ and Tau Aggregation
- (2018) Anne Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Iron promotes α-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion
- (2018) Yousheng Xiao et al. JOURNAL OF NEUROCHEMISTRY
- Iron Redox Chemistry Promotes Antiparallel Oligomerization of α-Synuclein
- (2018) Dinendra L. Abeyawardhane et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
- (2018) Gye Sun Jeon et al. MOLECULAR NEUROBIOLOGY
- Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects
- (2018) James Everett et al. Nanoscale
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese
- (2018) Natascha A. Wolff et al. Scientific Reports
- The Aging of Iron Man
- (2018) Azhaar Ashraf et al. Frontiers in Aging Neuroscience
- hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway
- (2018) Malgorzata Halon-Golabek et al. Journal of Cachexia Sarcopenia and Muscle
- Prion Protein Regulates Iron Transport by Functioning as a Ferrireductase
- (2018) Ajay Singh et al. JOURNAL OF ALZHEIMERS DISEASE
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
- (2018) Claudio Soto et al. NATURE NEUROSCIENCE
- A new era for understanding amyloid structures and disease
- (2018) Matthew G. Iadanza et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition
- (2017) Kuo-Chen Wu et al. NEUROBIOLOGY OF DISEASE
- Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
- (2017) Eleonora Carboni et al. NEUROMOLECULAR MEDICINE
- A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo
- (2017) Banibrata Das et al. NEUROPHARMACOLOGY
- Mitochondrial Ferritin Deletion Exacerbatesβ-Amyloid-Induced Neurotoxicity in Mice
- (2017) Peina Wang et al. Oxidative Medicine and Cellular Longevity
- A drastic superoxide-dependent oxidative stress is prerequisite for the down-regulation of IRP1: Insights from studies on SOD1-deficient mice and macrophages treated with paraquat
- (2017) Anna Milczarek et al. PLoS One
- Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders
- (2017) Abhishek Asthana et al. Scientific Reports
- Elucidating the function of the prion protein
- (2017) Giuseppe Legname PLoS Pathogens
- Cellular Regulation of Amyloid Formation in Aging and Disease
- (2017) Esther Stroo et al. Frontiers in Neuroscience
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
- (2017) David I. Finkelstein et al. Acta Neuropathologica Communications
- Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
- (2017) Antonio Martin-Bastida et al. Scientific Reports
- Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic Mouse
- (2016) Jessica L. Billings et al. ACS Chemical Neuroscience
- Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
- (2016) Emma Deas et al. ANTIOXIDANTS & REDOX SIGNALING
- Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila
- (2016) Zhou-Jing Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice
- (2016) Sagit Golko-Perez et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity
- (2016) Jack T. Rogers et al. JOURNAL OF NEUROCHEMISTRY
- Brain Iron Metabolism Dysfunction in Parkinson’s Disease
- (2016) Hong Jiang et al. MOLECULAR NEUROBIOLOGY
- Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1G93A Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis
- (2016) Anna Gajowiak et al. Frontiers in Molecular Neuroscience
- Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
- (2016) J. M. G. van Bergen et al. Scientific Reports
- Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice
- (2015) David I. Finkelstein et al. ACS Chemical Neuroscience
- Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
- (2015) Toshiki Uchihara et al. ACTA NEUROPATHOLOGICA
- Toxic species in amyloid disorders: Oligomers or mature fibrils
- (2015) Vibha Taneja et al. Annals of Indian Academy of Neurology
- Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease
- (2015) K. Rajasekhar et al. CHEMICAL COMMUNICATIONS
- Iron is a specific cofactor for distinct oxidation- and aggregation-dependent A toxicity mechanisms in a Drosophila model
- (2015) S. Ott et al. Disease Models & Mechanisms
- Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
- (2015) Eleonora Carboni et al. Metallomics
- α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons
- (2015) Richard Ortega et al. MOLECULAR NEUROBIOLOGY
- Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation
- (2015) Jared M. Fine et al. NEUROSCIENCE LETTERS
- KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity
- (2015) Ulf Dettmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tau aggregation and its interplay with amyloid-β
- (2014) Rebecca M. Nisbet et al. ACTA NEUROPATHOLOGICA
- Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial
- (2014) Massimo Pandolfo et al. ANNALS OF NEUROLOGY
- Evidence of Redox-Active Iron Formation Following Aggregation of Ferrihydrite and the Alzheimer’s Disease Peptide β-Amyloid
- (2014) James Everett et al. INORGANIC CHEMISTRY
- Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide -amyloid (1-42)
- (2014) J. Everett et al. Journal of the Royal Society Interface
- Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein
- (2014) Priyanjalee Banerjee et al. NEUROMOLECULAR MEDICINE
- β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin
- (2014) Bruce X. Wong et al. PLoS One
- The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
- (2014) David B. Lovejoy et al. Frontiers in Aging Neuroscience
- Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
- (2013) David Devos et al. ANTIOXIDANTS & REDOX SIGNALING
- Prion protein conversion induced by trivalent iron in vesicular trafficking
- (2013) Bo-Ran Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- Mitochondrial Ferritin Attenuates β-Amyloid-Induced Neurotoxicity: Reduction in Oxidative Damage Through the Erk/P38 Mitogen-Activated Protein Kinase Pathways
- (2012) Wen-Shuang Wu et al. ANTIOXIDANTS & REDOX SIGNALING
- Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
- (2012) Georg Nübling et al. Molecular Neurodegeneration
- Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake
- (2012) Ling Xie et al. NEUROCHEMISTRY INTERNATIONAL
- Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
- (2012) Chuang Guo et al. NEUROCHEMISTRY INTERNATIONAL
- α-Synuclein expression is modulated at the translational level by iron
- (2012) Fabia Febbraro et al. NEUROREPORT
- Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis
- (2012) M. Hadzhieva et al. NEUROSCIENCE
- Phosphorylation of α-Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of α-Synuclein in the Pathogenesis of Parkinson’s Disease and Related Disorders
- (2011) Yu Lu et al. ACS Chemical Neuroscience
- Single particle analysis of tau oligomer formation induced by metal ions and organic solvents
- (2011) Benedikt Bader et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking
- (2011) Todd J Cohen et al. EMBO JOURNAL
- Prion protein expression level alters regional copper, iron and zinc content in the mouse brain
- (2011) M. Jake Pushie et al. Metallomics
- Dementia: A problem for our age
- (2011) Alison Abbott NATURE
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Prevention of Motor Neuron Degeneration by Novel Iron Chelators in SOD1G93A Transgenic Mice of Amyotrophic Lateral Sclerosis
- (2011) Qian Wang et al. Neurodegenerative Diseases
- Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome)
- (2011) Takashi Haraguchi et al. NEUROPATHOLOGY
- Alpha-Synuclein Is a Cellular Ferrireductase
- (2011) Paul Davies et al. PLoS One
- A soluble -synuclein construct forms a dynamic tetramer
- (2011) W. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ageing, neurodegeneration and Parkinson's disease
- (2010) J. V. Hindle AGE AND AGEING
- Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
- (2010) Daniel Velasco-Sánchez et al. CEREBELLUM
- Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
- (2010) Beinan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase
- (2010) Shinji Higashi et al. NEUROCHEMISTRY INTERNATIONAL
- Oxidative Stress Partially Contributes to Iron-Induced Alpha-Synuclein Aggregation in SK-N-SH Cells
- (2010) Wenjing Li et al. NEUROTOXICITY RESEARCH
- Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in aDrosophilamodel of Alzheimer’s disease
- (2009) Thomas Rival et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
- (2009) Lana Kupershmidt et al. FASEB JOURNAL
- Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2009) S. Y. Jeong et al. JOURNAL OF NEUROSCIENCE
- Prion Protein (PrP) Knock-Out Mice Show Altered Iron Metabolism: A Functional Role for PrP in Iron Uptake and Transport
- (2009) Ajay Singh et al. PLoS One
- Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
- (2009) S. Soe-Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders
- (2009) Ajay Singh et al. PLoS Pathogens
- Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers
- (2008) Marcus Kostka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now